Ep. 812 - Weight loss drugs: Medicare limits and market demand on a collision course!
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Ep. 812 - Weight loss drugs: Medicare limits and market demand on a collision course!
-
ナレーター：
-
著者：
このコンテンツについて
Patients with Medicare Advantage insurance coverage: rural hospitals are asking themselves whether they can afford to keep accepting them!
This is the subject of our "Medicare Advantage Minute" today.
In "Your Medicare Benefits 2025" we learn how Medicare would cover home infusion therapy services.
Then we spot check some rate increase statistics in order to determine whether inflationary trends are still exerting upward pressure on insurance premiums.
They are.
Medicare is not allowed to provide and pay for drugs whose only function is weight loss. Some of the newly distributed GLP-1 drugs provide weight loss effects as well as beneficial treatment of heart disease and type 2 diabetes. This causes a high demand for these expensive meds.
Finally, we learn what some pinko organization thinks are the best states and worst states for overall health care access.
Contact me at: DBJ@MLMMailbag.com
(Most severe critic: A+) Visit us on: BabyBoomer.ORG
Inspired by:
"MEDICARE FOR THE LAZY MAN 2025; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers.
Official website: https://www.MedicareForTheLazyMan.com.